Skip to Main Content

Paper Details

KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas.
British Journal of Dermatology
13
2017
BRAF, CD117, KIT, KIT mutations, Ki-67, NF1, NRAS, TERT promoter, TP53, brafv600e, melanoma, neurofibromin, nrasq61r, p53, vulvar melanomas
Author NameAffiliation
Dora Dias-SantagataMassachusetts General Hospital and Harvard Medical School
Mai P HoangMassachusetts General Hospital and Harvard Medical School
  • 1 - 2

Datasets

Release 1.2